Sanofi Pasteur and Merck plan to end their joint vaccines operations in Europe. After concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage their product portfolios and pursue separate growth strategies in Europe.   The joint venture Sanofi Pasteur MSD, owned on a 50/50 basis, was created in 1994 to develop and commercialize vaccines from both companies’ pipelines in 19 European countries. Numer...